Treatment Options

At Fauquier Health, we follow the recommendations of the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and the U.S. Food and Drug Administration (FDA) regarding COVID-19 treatment options for patients requiring hospitalization. When deemed clinically appropriate by a patient’s physician, we offer the below FDA approved treatment options:

• Dexamethasone (anti-inflammatory)
• Remdesivir (anti-viral)
• Baricitinib (anti-inflammatory)

When deemed clinically appropriate for patients not requiring hospitalization, we also can provide Sotrovimab, which is a Monoclonal Antibody (mAb) Therapy treatment that has been proven effective against the Omicron variant.

Consistent with NIH Treatment Guidelines, our COVID-19 order set does not include standard treatment with:

• Ivermectin
• Hydroxychloroquine
• Plasma

 VISIT VACCINES.GOV